What basal cell carcinoma is
Basal cell carcinoma (BCC) is the most common type of skin cancer, accounting for about 8 in 10 of all diagnosed skin cancers. It develops from the basal cells in the deepest part of the outer layer of the skin, usually on areas exposed to the sun such as the head and neck. It grows slowly, and it is very rare for a BCC to spread to another part of the body — it can, however, invade deeper tissues if left untreated.
It is also one of the most treatable cancers. The American Cancer Society estimates that only around 2,000 out of the 5 million Americans diagnosed with either basal cell or squamous cell carcinoma each year will die as a result of their cancer — death from basal cell cancer is uncommon, and cure rates exceed 95% when it is caught and treated early with clean excision margins.
How underwriters look at it
Carriers treat cancer types very differently, and basal cell skin cancer is generally the lightest touch of all: impaired-risk broker guides describe it as generally ignored by underwriters, treated as a non-event once removed. What they check is narrow — the lesion type, that the excision was complete with clear margins, and that routine follow-up is in place.
A single localised cancer treated successfully is viewed very differently from a cancer that recurred even once. Multiple recurrences, incomplete removal, a high-risk location, or associated conditions can change the assessment — and the rest of the application still matters: a basal cell history does not cancel out the blood pressure, cholesterol and smoking questions, which are underwritten on the same logic as the site's guides to life insurance for diabetics and life insurance with high blood pressure.
What rate class to expect
No rate class is promised for any applicant here, but the range impaired-risk broker guides report is unusually favourable. Their underwriting tables list basal cell skin cancer with no waiting period required and Standard or Preferred as the reported outcome, described as “generally disregarded by underwriters; treated as non-event.” Several brokers report that many basal cell applicants qualify for Standard Non-Smoker rates with no premium increase, with the treated, clear-margin case viewed much like a healed surgical procedure — and some carriers may offer better than Standard for thin BCCs with excellent surgical outcomes and otherwise clean profiles.
Multiple carcinomas are the case that changes the picture: a history of several lesions may still be insurable at an affordable rate, but there could be an additional premium depending on the specific situation. And the comparison that matters is with melanoma, which is rated by stage and years since excision and is a much harder file — a basal cell diagnosis is not a melanoma diagnosis, and an application should never be priced as if it were.
What to prepare
Have the record in the order an underwriter reads it: the pathology report confirming basal cell carcinoma and the excision margins, the treatment records and dates, confirmation that removal was complete, any follow-up notes, how many lesions there have been and where, and any other health condition. A single, fully removed lesion with clean margins and a clear follow-up record is the simplest version of this file.
Apply after treatment is complete, not during it. A lesion still awaiting excision, or one whose margins are not yet confirmed clear, is an open file — and an open file is usually postponed until the record is closed. Disclose the condition exactly as the application asks it: a material omission risks the claim itself under contestability.
If the first answer is a rating or a decline
A rating is not a rejection: it is a higher premium for the same benefit, and its size varies by carrier — carrier underwriting guidelines for skin cancer are not standardised, so the same file can be standard at one carrier and rated at another. That variation is why a second and third opinion are worth the effort for any rated case.
A decline for a basal cell history alone would be unusual, and it is worth asking what else the carrier saw in the file. If fully underwritten cover is not available, simplified-issue policies (health questions, no exam) and, as a last resort, guaranteed-issue policies (no health questions, higher price per dollar, usually capped benefits and graded early benefits) remain — but work down that ladder in order, fully underwritten first, simplified next, guaranteed last, because each step down costs more per dollar.
Worked example
Consider two ILLUSTRATIVE applicants. The first had a single basal cell carcinoma on the nose, excised two years ago with clear margins and no recurrence, with an otherwise clean application. The second has had four basal cell carcinomas at different sites over three years, one of which is still awaiting excision. An underwriter would view the first application very differently from the second — not because one diagnosis word is “better” in the abstract, but because complete removal, clear margins, no recurrence and a closed record point in one direction, while multiple lesions and open treatment point in another. These are ILLUSTRATIVE contrasts to explain underwriting logic; they predict no real applicant's rate class, and no premium figure is asserted for either person.
Illustrative example only — not a fact about any real policy.